文献速递妇科

骶棘韧带固定术联合移植物与阴式子宫切除加宫骶韧带悬吊术治疗子宫阴道脱垂5年随机试验结果

Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial.
PubMed 文献 · Am J Obstet Gynecol · 2021-03-12

BACKGROUND: Vaginal hysterectomy with suture apical suspension is commonly performed for uterovaginal prolapse. Sacrospinous hysteropexy with graft (vaginal mesh hysteropexy) is an alternative, although in 2019 the Food and Drug Administration removed this mesh product from the U…

要点

  • 骶棘韧带固定术联合移植物5年复合失败率低于阴式子宫切除加宫骶韧带悬吊术。
  • 两组患者报告盆腔 floor 症状、脱垂症状、肠道功能、生活质量等无显著差异。
  • 移植物组网片暴露率8%,子宫切除组术后肉芽组织12%、缝线暴露21%。

核心结论

  • 对于有症状的子宫阴道脱垂行阴道手术的女性,骶棘韧带固定术联合移植物5年复合失败率低于阴式子宫切除加宫骶韧带悬吊术。

研究设计与样本

  • 多中心随机优效性临床试验,纳入183例子宫阴道脱垂绝经后女性,随机分配至骶棘韧带固定术联合移植物组(93例)或阴式子宫切除加宫骶韧带悬吊术组(90例),随访60个月。

主要发现

  • 除泌尿生殖痛苦量表外,患者报告的盆腔 floor 症状、脱垂症状、肠道功能、生活质量、身体形象和盆腔疼痛无组间差异。
  • 不良事件:移植物组网片暴露8%,子宫切除组0%;术后12周以上肉芽组织1% vs 12%,缝线暴露3% vs 21%。

临床怎么用

  • 对于有症状子宫阴道脱垂需阴道手术的绝经后女性,可考虑骶棘韧带固定术联合移植物以降低5年复合失败率。
  • 术前应告知患者网片暴露风险及两种术式患者报告结局无显著差异。

局限性

  • 研究在美国9个中心进行,结果外推需谨慎。
  • 2019年美国FDA将该网片产品撤市,可能影响临床可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaginal hysterectomy with suture apical suspension is commonly performed for uterovaginal prolapse. Sacrospinous hysteropexy with graft (vaginal mesh hysteropexy) is an alternative, although in 2019 the Food and Drug Administration removed this mesh product from the United States market. OBJECTIVE: Our objective was to compare the efficacy and adverse events of these 2 procedures. STUDY DESIGN: At 9 clinical sites in the United States National Institutes of Health and National Institute of Child Health and Human Development Pelvic Floor Disorders Network, 183 postmenopausal women requesting vaginal surgery for symptomatic uterovaginal prolapse were enrolled in a multisite randomized superiority clinical trial, comparing a sacrospinous hysteropexy with graft (hysteropexy) with a vaginal hysterectomy with uterosacral ligament suspension (hysterectomy). Participants consented to remain masked to treatment assignment for the study duration. Study visits were conducted at 6-month intervals through 60 months. The primary treatment failure composite outcome (retreatment of prolapse, prolapse beyond the hymen, or prolapse symptoms) was evaluated with survival modeling. Secondary outcomes included complications or adverse events, individual anatomic measures of the pelvic organ prolapse quantification examination, and presence, severity, and impact and bother of prolapse, urinary, bowel, and pain symptoms as measured by validated questionnaires. The 3-year published results suggested better primary outcomes with sacrospinous hysteropexy with graft, but the differences were not statistically significant (P=.06). This study reports the 5-year outcomes. RESULTS: A total of 183 women with a mean age of 66 years were randomized between April 2013 and February 2015; 93 were randomized to hysteropexy and 90 were randomized to hysterectomy. Notably, 175 were included in the trial, and 156 (89%) completed the 5-year follow-up. The primary outcome showed fewer failures for hysteropexy than hysterectomy through 5 years (adjusted hazard ratio, 0.58; 95% confidence interval, 0.36-0.94; P=.03), with failure rates of 37% vs 54%, respectively, resulting in a difference of -18% (95% confidence interval, -33% to -3%) at 5 years. With the exception of the Urogenital Distress Inventory, no group differences were demonstrated in patient-reported pelvic floor symptoms, prolapse symptoms, bowel function symptoms, general quality of life, body image, or pelvic pain. At their last visit through 5 years, 70% of participants (129 of 183) reported they remained masked to their treatment with no difference in masking between groups. Adverse events for hysteropexy vs hysterectomy included mesh exposure (8% vs 0%), granulation tissue after 12 weeks (1% vs 12%), and suture exposure after 12 weeks (3% vs 21%), respectively. CONCLUSION: Among women with symptomatic uterovaginal prolapse undergoing vaginal surgery, sacrospinous hysteropexy with graft resulted in a lower composite failure rate than vaginal hysterectomy through 5 years. There were no meaningful differences in patient-reported outcomes between groups. Our results suggest that this vaginal mesh hysteropexy procedure should be made available to patients.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nager CW, Visco AG, Richter HE, et al. Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial. Am J Obstet Gynecol. 2021. PMID: 33716071. doi:10.1016/j.ajog.2021.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。